New study aims to predict dangerous clot complications early
NCT ID NCT07491094
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 400 adults diagnosed with pulmonary embolism (a blood clot in the lungs) at a Swedish hospital. Researchers will repeatedly check heart tests and blood markers during the first 48 hours to see if early changes can better predict who will worsen. The goal is to improve understanding and create a long-term follow-up system, not to test a new drug or treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better ways to predict which patients with pulmonary embolism are at risk of getting worse, helping doctors make faster, more informed decisions.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve health. The findings may not apply to all hospitals or patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM ACUTE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sahlgrenska University Hospital/Mölndal
NOT_YET_RECRUITINGGothenburg, Region Västra Götaland, Sweden
-
Sahlgrenska University Hospital/Sahlgrenska
RECRUITINGGothenburg, Region Västra Götaland, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sahlgrenska University Hospital/Östra
NOT_YET_RECRUITINGGothenburg, Region Västra Götaland, Sweden